Reno, NVNCT06942520Now EnrollingIRB Ready

Diabetic Macular Edema Clinical Trial in Reno, NV

Access cutting-edge diabetic macular edema treatment through this phase 2 clinical trial at a research site in Reno. Study-provided care at no cost to qualified participants.

Sponsored by Sierra Eye Associates

Quick Self-Assessment

See if you qualify for this Reno location

Preparing your pre-screening questions…

Expert Care in Reno

Access diabetic macular edema specialists at no cost

IRB Approved

This study follows strict safety protocols and ethical guidelines

No-Cost Care

All study-related diabetic macular edema treatment provided free

Apply for This Reno Location

Check if you qualify for this diabetic macular edema clinical trial in Reno, NV

Secure & Confidential

Your information is protected and will only be shared with the research team.

Why Participate?

  • No-Cost Study Care

  • Local to Reno

    Convenient for NV residents

  • Cutting-Edge Treatment

    Access to innovative therapies

  • Expert Medical Care

    Close monitoring by specialists

  • Possible Compensation*

    For time and travel

*Compensation varies by study. Confirm details with coordinator.

Simple Process

  1. 1Submit this form
  2. 2Phone screening
  3. 3Visit Reno site if eligible
  4. 4Begin participation

About This Diabetic Macular Edema Study in Reno

Phase 2 open label, randomized, active controlled, dose-ranging trial in adults with Center Involved - Diabetic Macular Edema (CI - DME)

Sponsor: Sierra Eye Associates

Who Can Participate

Inclusion Criteria

Type I or Type II diabetes mellitus with center involving diabetic macular edema with previous treatment
BCVA in study eye 78 to 25 ETDRS letters (\~20/32 to 20/320) at screening
Decreased visual acuity attributable primarily due to CI - DME
Demonstrate clinical response to aflibercept injection in the study eye
Provide written informed consent

Exclusion Criteria

Women of childbearing potential
Neovascularization in the study eye from a cause other than DR
Evidence in the study eye of optic nerve pallor on clinical examination
History of pan retinal photocoagulation in the study eye
Any concurrent ocular condition in the study eye other than CI-DME that could require surgical intervention within 6 months or any condition in the study eye that may increase the risk to the participant, require either medical or surgical intervention during the study to prevent or treat vision loss, or interfere with the study procedures or assessments
Presence of an implant in the study eye at screening (excluding intraocular lens)
Any condition in the investigator's opinion that could limit VA improvement in the study eye
Active or history of glaucoma, steroid response, or ocular hypertension
Any prior intravitreal steroid injection in the study eye within 6 months prior to screening, administration in the study eye of Ozudrex® within 12 months prior to screening, or administration in the study eye if Iluven® within 36 months prior to screening
Diabetic macular edema diagnosis ≥ 7 years
History of chronic renal failure requiring dialysis or kidney transplant
Participation in any other gene therapy study or receipt of any investigational product within 30 days prior to enrollment or 5 half-lives of the investigational product, whichever is longer, or any plans to use an investigational product within 6 months following enrollment Note: Other inclusion/exclusion criteria apply

Not sure if you qualify? Submit your interest and a study coordinator will help determine your eligibility.

Frequently Asked Questions

Q:Is this study available in Reno?

Yes, this clinical trial (NCT06942520) has an active research site in Reno, NV that is currently enrolling participants.

Q:Is it safe to participate?

Clinical trials follow strict safety guidelines and ethical standards. This study has been reviewed and approved, and participants are closely monitored by medical professionals. You can withdraw at any time.

Q:Will I be compensated?

Many clinical trials offer compensation for your time and travel expenses. Specific compensation details will be discussed during the screening process. All study-related medical care is provided at no cost.

Q:Can I leave the trial if I change my mind?

Absolutely. Participation is completely voluntary. You have the right to withdraw from the study at any time, for any reason, without penalty.

Still have questions? Our study coordinators are here to help.

Diabetic Macular Edema Treatment Options in Reno, NV

If you're searching for diabetic macular edema treatment options in Reno, NV, this clinical trial (NCT06942520) may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.

Our Reno research site is actively enrolling participants for this phase 2 clinical trial. You'll receive care from experienced diabetic macular edema specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.

Looking for more options? Browse all diabetic macular edema clinical trials near you to find additional studies recruiting in your area.

More Essential Tremor Trials in Reno, NV

See all essential tremor clinical trials recruiting in Reno — not just this study.

Browse Essential Tremor Trials in Reno →

Browse More Trials by Condition

Essential Tremor TrialsType 2 Diabetes TrialsErectile Dysfunction TrialsInterstitial Cystitis TrialsDiabetic Retinopathy TrialsAll Conditions →

Ready to Join in Reno?

Take the first step toward participating in this groundbreaking clinical trial

Secure · Expert Care · Reno, NV